NCT01228344View on ClinicalTrials.gov

Surveillance of Effectiveness/Safety of Artemether-lumefantrine in Patients With Malaria

CompletedOBSERVATIONAL
Enrollment

324

Participants

Timeline

Start Date

May 1, 2010

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Malaria
Interventions
OTHER

Artemether-lumefantrine

Trial Locations (1)

Unknown

Centers for Disease Control and Prevention,GA, Atlanta

Sponsors
All Listed Sponsors
collaborator

Centers for Disease Control and Prevention

FED

lead

Novartis Pharmaceuticals

INDUSTRY